Metraipolis › archive › dc_21bc9c04cdfe

Progress of Immunotherapies in Parkinson's Disease — Europe PMC PMID:42227981

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42227981
DOI
10.1002/cns.70964
License (as archived)
solo-consultazione
Archived
2026-11-01T01:50:54.881Z
SHA-256 of the archived text
3034e9e72045613520c541dae2211b29f238bedf8219a6751dda66d43b342841
Stable URL of this page
https://metraipolis.com/documento/dc_21bc9c04cdfe

How to cite

Progress of Immunotherapies in Parkinson's Disease — Europe PMC PMID:42227981 — Europe PMC (en), https://europepmc.org/article/MED/42227981 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_21bc9c04cdfe (Metraipolis archive dc_21bc9c04cdfe, sha256 3034e9e72045613520c541dae2211b29f238bedf8219a6751dda66d43b342841)
BibTeX
@misc{dc21bc9c04cdfe,
  title = {Progress of Immunotherapies in Parkinson's Disease — Europe PMC PMID:42227981},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42227981},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_21bc9c04cdfe; sha256 3034e9e72045613520c541dae2211b29f238bedf8219a6751dda66d43b342841},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42227981. Agents can read the archived copy with the MCP tool read_document.